Stocks
Amicus Therapeutics (FOLD) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -182.3% | -93.1% | -66.4% | -60.6% | -23.1% | -1.86% | ||
| Changes by years, y/y, % | +164pp | +89pp | +27pp | +6pp | +38pp | -41.9% | |||
Amicus Therapeutics. EBITDA margin, %
Amicus Therapeutics. EBITDA margin, changes, pp
Amicus Therapeutics (FOLD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -9.17% | -14.5% | -26.3% | 11.7% | 15.3% | -1.86% | |
| Changes by years, y/y, % | +13pp | +49pp | +20pp | +37pp | +24pp | |||
| Changes by quarters, q/q, % | +17pp | -5pp | -12pp | +38pp | +4pp | |||
